IR@PKUHSC  > 北京大学第一临床医学院  > 核医学科
学科主题临床医学
MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3
Fan, Zhongyi1; Cui, Hanzhi2; Xu, Xiaojie3; Lin, Zhi1; Zhang, Xuelin1; Kang, Lei4; Han, Baiyu5; Meng, Jing1; Yan, Zhifeng1; Yan, Xiang1; Jiao, Shunchang1
关键词miR-125a cervical cancer cell growth metastasis STAT3
刊名ONCOTARGET
2015-09-22
6期:28页:25266-25280
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Cell Biology
研究领域[WOS]Oncology ; Cell Biology
关键词[WOS]EPITHELIAL-MESENCHYMAL TRANSITION ; LYMPH-NODE METASTASIS ; HUMAN-PAPILLOMAVIRUS ; BREAST-CANCER ; UNFAVORABLE PROGNOSIS ; GERMLINE MUTATION ; SIGNAL TRANSDUCER ; EXPRESSION ; CARCINOMA ; CELLS
英文摘要

MiR-125a has been characterized as a tumor suppressor in several cancers. However, the role of miR-125a in cervical cancer is unknown. In this study, we found the expression of miR-125a was downregulated in cervical cancer patients, and negatively correlated with the tumor size, FIGO stage, and preoperative metastasis. Kaplan-Meier analysis showed that miR-125a expression predicted favorable outcome for cervical cancer patients. Dual luciferase assays identified the STAT3 gene as a novel direct target of miR-125a. Functional studies showed that miR-125a overexpression significantly suppressed the growth, invasion and epithelial-mesenchymal transition (EMT) of cervical cancer cells both in vitro and in vivo via decreasing STAT3 expression. Moreover, miR-125a conferred to G2/M cell cycle arrest, accompanied by inhibition of several G2/M checkpoint proteins. Mechanistically, inactivation of miR-125a during cervical carcinogenesis was caused by HPV suppression of p53 expression. Clinically, STAT3, the expression of which, predicted poorer outcome, was inversely correlated with miR-125a in cervical cancer. These data highlight the importance of miR-125a in the cell proliferation and progression of cervical cancer, and indicate that miR-125a may be a useful therapeutic target for cervical cancer.

语种英语
WOS记录号WOS:000363160100059
项目编号2015MS-010 ; 81472589 ; 31100604 ; Z141102001814055
资助机构General Program of 309th Hospital of PLA ; National Natural Science Foundation ; Beijing Nova Program
引用统计
被引频次:36[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/58403
专题北京大学第一临床医学院_核医学科
作者单位1.Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China
2.309th Hosp PLA, Dept Oncol, Beijing, Peoples R China
3.Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China
4.Peking Univ, Hosp 1, Dept Nucl Med, Beijing 100871, Peoples R China
5.264th Hosp PLA, Dept Endocrinol & Metablism, Taiyuan, Shanxi, Peoples R China
推荐引用方式
GB/T 7714
Fan, Zhongyi,Cui, Hanzhi,Xu, Xiaojie,et al. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3[J]. ONCOTARGET,2015,6(28):25266-25280.
APA Fan, Zhongyi.,Cui, Hanzhi.,Xu, Xiaojie.,Lin, Zhi.,Zhang, Xuelin.,...&Jiao, Shunchang.(2015).MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.ONCOTARGET,6(28),25266-25280.
MLA Fan, Zhongyi,et al."MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3".ONCOTARGET 6.28(2015):25266-25280.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Fan, Zhongyi]的文章
[Cui, Hanzhi]的文章
[Xu, Xiaojie]的文章
百度学术
百度学术中相似的文章
[Fan, Zhongyi]的文章
[Cui, Hanzhi]的文章
[Xu, Xiaojie]的文章
必应学术
必应学术中相似的文章
[Fan, Zhongyi]的文章
[Cui, Hanzhi]的文章
[Xu, Xiaojie]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。